Next-Generation Ultrasonography System

A wearable, AI-powered ultrasonography system enabling real-time, high-resolution 3D imaging and automated diagnosis, revolutionizing healthcare diagnostics and treatment planning.

The original ultrasonography system patent (Japanese Patent Application No. 2020-150289) has limitations in terms of image resolution, sensor sensitivity, and processing power. The present inventive concept addresses these limitations by introducing wearable, AI-driven ultrasonography technology that enables real-time, high-resolution 3D imaging and automated diagnosis.

The new inventive concept comprises a wearable ultrasonic sensor array, a neural network-based processor, and a cloud-based database. The wearable sensor array is configured to be worn on a subject's body, providing real-time sensor data to the neural network-based processor. The processor applies machine learning algorithms to generate high-resolution 3D images of internal organs and automate diagnosis and treatment planning. The cloud-based database stores a library of reference images for automated diagnosis and treatment planning.

The new claims introduce the following novel and non-obvious features: wearable ultrasonic sensor arrays, neural network-based processing, and cloud-based databases for automated diagnosis and treatment planning. These features overcome the limitations of the original patent and provide a paradigm shift in ultrasonography technology.

Alternative embodiments of the inventive concept could include handheld ultrasonography probes with built-in AI processors, flexible ultrasonic sensor arrays for wearable devices, and low-power wireless transmitters for real-time sensor data transmission. Variations could also include different machine learning algorithms, sensor array configurations, and database structures.

The next-generation ultrasonography system has significant commercial potential in the healthcare industry, particularly in fields such as cardiology, oncology, and obstetrics. The system could be marketed as a diagnostic tool for hospitals, clinics, and medical research institutions, as well as for remote patient monitoring and telemedicine applications.